In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Recently, Prime Minister Narendra Modi has launched Jan Samarth, a credit-linked portal linked to
Instructions have been issued to arrest migrants from the Fahheel area who demonstrated after Fri
India has faced defeat in the last match of the three-match ODI series against Australia. In the
The Indian team has fallen 0-1 in the five-Test series after losing the first Test at the hands o
China has been the victim of a severe outbreak of the Corona epidemic for more than a month. Acco
Home-Car Loans Key interest rates released to make cheaper, know what RBI announced
After reviewing the monetary policy, the central bank on Thursday announced to maintain the statu
The Online Gaming Promotion and Regulation Bill, 2025, has now become a law after the President's
Veteran Hindi cinema actor Manoj Kumar has merged into the five elements. 'Bharat Kumar' was crem
Nowadays more than one web series is coming on OTT. If you are planning to watch web series this
Rahul Gandhi's comment and this joint statement of Imran Khan-Xi Jinping
Congress leader Rahul Gandhi said in the Lok Sabha last week that the Modi government has committ
